Gainers
- ENvue Medical (NASDAQ:FEED) shares rose 49.1% to $0.61 during Wednesday's after-market session. The market value of their outstanding shares is at $2.4 million.
- Omeros (NASDAQ:OMER) stock moved upwards by 22.46% to $16.79. The company's market cap stands at $984.3 million. As per the news, the Q2 earnings report came out today.
- Bone Biologics (NASDAQ:BBLG) stock increased by 13.2% to $0.74. The company's market cap stands at $1.6 million.
- Biote (NASDAQ:BTMD) stock rose 9.85% to $1.56. The market value of their outstanding shares is at $46.7 million.
- Redhill Biopharma (NASDAQ:RDHL) stock moved upwards by 8.32% to $0.64. The company's market cap stands at $3.6 million.
- RenovoRx (NASDAQ:RNXT) stock moved upwards by 7.14% to $1.2. The company's market cap stands at $51.8 million. As per the press release, Q2 earnings came out today.
Losers
- Outlook Therapeutics (NASDAQ:OTLK) shares fell 16.2% to $0.92 during Wednesday's after-market session. The company's market cap stands at $211.3 million.
- Valion Bio (NASDAQ:VBIO) stock fell 14.61% to $0.19. The market value of their outstanding shares is at $1.2 million.
- Modular Medical (NASDAQ:MODD) stock decreased by 13.05% to $1.8. The company's market cap stands at $10.9 million.
- AngioDynamics (NASDAQ:ANGO) shares fell 11.37% to $13.96. The market value of their outstanding shares is at $650.9 million.
- Curis (NASDAQ:CRIS) stock decreased by 10.78% to $1.49. The market value of their outstanding shares is at $4.8 million.
- MaxCyte (NASDAQ:MXCT) stock fell 9.46% to $1.15. The market value of their outstanding shares is at $132.8 million. The company's, Q2 earnings came out today. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Login to comment